Simon Frantz. Show Affiliations »
Abstract
Mesh： See more » Cardiovascular Diseases/etiologyClinical Trials as TopicCyclooxygenase 2Cyclooxygenase 2 InhibitorsCyclooxygenase Inhibitors/adverse effectsDrug IndustryHumansIsoenzymes/metabolismLactones/adverse effectsMembrane ProteinsProstaglandin-Endoperoxide Synthases/metabolismRiskSulfones
Substances： See more » Cyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsIsoenzymesLactonesMembrane ProteinsSulfonesrofecoxibCyclooxygenase 2PTGS2 protein, humanProstaglandin-Endoperoxide Synthases
Year: 2004 PMID： 15558856 DOI： 10.1038/nrd1560
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694